Weil Company Inc. Has $5.34 Million Stock Holdings in Houlihan Lokey, Inc. (NYSE:HLI)

Weil Company Inc. increased its holdings in shares of Houlihan Lokey, Inc. (NYSE:HLI) by 14.7% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 39,577 shares of the financial services provider’s stock after purchasing an additional 5,081 shares during the period. Houlihan Lokey makes up about 1.9% of Weil Company Inc.’s holdings, making the stock its 14th biggest position. Weil Company Inc.’s holdings in Houlihan Lokey were worth $5,337,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in HLI. Norges Bank acquired a new stake in shares of Houlihan Lokey in the 4th quarter valued at about $70,225,000. Capital International Investors grew its stake in Houlihan Lokey by 56.7% in the fourth quarter. Capital International Investors now owns 792,073 shares of the financial services provider’s stock valued at $94,977,000 after acquiring an additional 286,746 shares during the period. Sei Investments Co. increased its holdings in shares of Houlihan Lokey by 39.1% during the fourth quarter. Sei Investments Co. now owns 693,248 shares of the financial services provider’s stock valued at $83,128,000 after acquiring an additional 194,867 shares in the last quarter. Principal Financial Group Inc. raised its position in shares of Houlihan Lokey by 819.2% during the fourth quarter. Principal Financial Group Inc. now owns 216,186 shares of the financial services provider’s stock worth $25,923,000 after purchasing an additional 192,668 shares during the period. Finally, Jennison Associates LLC lifted its holdings in shares of Houlihan Lokey by 87.2% in the 1st quarter. Jennison Associates LLC now owns 347,165 shares of the financial services provider’s stock worth $44,503,000 after purchasing an additional 161,753 shares in the last quarter. 78.07% of the stock is currently owned by institutional investors.

Houlihan Lokey Price Performance

HLI opened at $148.90 on Friday. Houlihan Lokey, Inc. has a 1 year low of $94.67 and a 1 year high of $157.58. The company has a market capitalization of $10.21 billion, a price-to-earnings ratio of 36.23 and a beta of 0.67. The firm’s fifty day moving average price is $146.86 and its two-hundred day moving average price is $135.62.

Houlihan Lokey (NYSE:HLI) last released its quarterly earnings results on Tuesday, July 30th. The financial services provider reported $1.22 earnings per share for the quarter, hitting the consensus estimate of $1.22. The business had revenue of $514.00 million for the quarter, compared to analysts’ expectations of $508.70 million. Houlihan Lokey had a net margin of 15.30% and a return on equity of 18.80%. The firm’s revenue for the quarter was up 23.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.89 earnings per share. As a group, equities analysts anticipate that Houlihan Lokey, Inc. will post 5.64 EPS for the current year.

Houlihan Lokey Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Sunday, September 15th. Stockholders of record on Tuesday, September 3rd will be issued a $0.57 dividend. This represents a $2.28 annualized dividend and a dividend yield of 1.53%. The ex-dividend date is Tuesday, September 3rd. Houlihan Lokey’s dividend payout ratio is presently 55.47%.

Insider Activity at Houlihan Lokey

In other Houlihan Lokey news, General Counsel Christopher M. Crain sold 1,000 shares of the business’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $155.29, for a total value of $155,290.00. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In other news, Director Gillian Beth Zucker sold 200 shares of the stock in a transaction that occurred on Tuesday, August 20th. The shares were sold at an average price of $152.49, for a total transaction of $30,498.00. Following the completion of the transaction, the director now directly owns 7,001 shares of the company’s stock, valued at approximately $1,067,582.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Christopher M. Crain sold 1,000 shares of Houlihan Lokey stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $155.29, for a total transaction of $155,290.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 19,419 shares of company stock valued at $2,788,303. 25.97% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Keefe, Bruyette & Woods restated a “market perform” rating and set a $154.00 price target (up previously from $139.00) on shares of Houlihan Lokey in a research note on Wednesday, July 31st. JPMorgan Chase & Co. decreased their target price on shares of Houlihan Lokey from $132.00 to $129.00 and set a “neutral” rating for the company in a research report on Wednesday, July 31st. Morgan Stanley upped their target price on shares of Houlihan Lokey from $131.00 to $148.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 23rd. Finally, UBS Group lifted their price target on Houlihan Lokey from $157.00 to $170.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. Five analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $150.25.

About Houlihan Lokey

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.